Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026)
Beam Therapeutics (BEAM) reported Prepaid Assets of $55.3 million for Q1 2026, up 99.92% year-over-year from $27.7 million in Q1 2025, and up 135.54% quarter-over-quarter from $23.5 million in Q4 2025.
Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Prepaid Assets data on file, last reported at $55.3 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $55.3 million, up 99.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.3 million (up 99.92% YoY), and the FY2025 annual result was $23.5 million, down 14.34% from the prior year.
- Prepaid Assets climbed to $55.3 million in Q1 2026 per BEAM's latest filing, from $23.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $55.3 million in Q1 2026 and troughed at $13.8 million in Q2 2022.
- A 5-year average of $23.6 million and a median of $23.5 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 100.57% in 2022, then declined 17.88% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $14.8 million in 2022, then soared by 43.39% to $21.2 million in 2023, then climbed by 29.49% to $27.4 million in 2024, then fell by 14.34% to $23.5 million in 2025, then jumped by 135.54% to $55.3 million in 2026.
- Business Quant data shows BEAM's Prepaid Assets at $55.3 million in Q1 2026, $23.5 million in Q4 2025, and $23.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Beam Therapeutics | 3.53 Bn | 3.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.30 Mn |
| Dec 31, 2025 | 23.48 Mn |
| Sep 30, 2025 | 23.58 Mn |
| Jun 30, 2025 | 25.13 Mn |
| Mar 31, 2025 | 27.66 Mn |
| Dec 31, 2024 | 27.41 Mn |
| Sep 30, 2024 | 19.78 Mn |
| Jun 30, 2024 | 21.28 Mn |
| Mar 31, 2024 | 27.16 Mn |
| Dec 31, 2023 | 21.17 Mn |
| Sep 30, 2023 | 24.08 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 23.56 Mn |
| Dec 31, 2022 | 14.76 Mn |
| Sep 30, 2022 | 14.36 Mn |
| Jun 30, 2022 | 13.78 Mn |
| Mar 31, 2022 | 16.88 Mn |
| Dec 31, 2021 | 7.36 Mn |
| Sep 30, 2021 | 8.02 Mn |
| Jun 30, 2021 | 12.71 Mn |